case study of myocardial infarction pdf

• Search Menu
• Volume 2024, Issue 4, April 2024 (In Progress)
• Volume 2024, Issue 3, March 2024
• Case of the Year
• MSF Case Reports
• Audiovestibular medicine
• Cardiology and cardiovascular systems
• Critical care medicine
• Dermatology
• Emergency medicine
• Endocrinology and metabolism
• Gastroenterology and hepatology
• Geriatrics and gerontology
• Haematology
• Infectious diseases and tropical medicine
• Medical ophthalmology
• Medical disorders in pregnancy
• Paediatrics
• Palliative medicine
• Pharmacology and pharmacy
• Radiology, nuclear medicine, and medical imaging
• Respiratory disorders
• Rheumatology
• Sexual and reproductive health
• Sports medicine
• Substance abuse
• Author Guidelines
• Submission Site
• Open Access
• Editorial Board
• Advertising and Corporate Services
• Journals Career Network
• Self-Archiving Policy
• Journals on Oxford Academic
• Books on Oxford Academic

Article Contents

Answer to part 1, answer to part 2, answer to part 3, answer to part 4, answer to part 5.

• < Previous

Educational Case: A 57-year-old man with chest pain

Contributed equally.

• Article contents
• Figures & tables
• Supplementary Data

Nikhil Aggarwal, Subothini Selvendran, Vassilios Vassiliou, Educational Case: A 57-year-old man with chest pain, Oxford Medical Case Reports , Volume 2016, Issue 4, April 2016, Pages 62–65, https://doi.org/10.1093/omcr/omw008

• Permissions Icon Permissions

This is an educational case report including multiple choice questions and their answers. For the best educational experience we recommend the interactive web version of the exercise which is available via the following link: http://www.oxfordjournals.org/our_journals/omcr/ec01p1.html

A 57 year-old male lorry driver, presented to his local emergency department with a 20-minute episode of diaphoresis and chest pain. The chest pain was central, radiating to the left arm and crushing in nature. The pain settled promptly following 300 mg aspirin orally and 800 mcg glyceryl trinitrate (GTN) spray sublingually administered by paramedics in the community. He smoked 20 cigarettes daily (38 pack years) but was not aware of any other cardiovascular risk factors. On examination he appeared comfortable and was able to complete sentences fully. There were no heart murmurs present on cardiac auscultation. Blood pressure was 180/105 mmHg, heart rate was 83 bpm and regular, oxygen saturation was 97%.

What is the most likely diagnosis?

An ECG was requested and is shown in figure 1.

How would you manage the patient? (The patient has already received 300 mg aspirin).

30 minutes later the patient's chest pain returned with greater intensity whilst waiting in the emergency department. Now, he described the pain as though “an elephant is sitting on his chest”. The nurse has already done an ECG by the time you were called to see him. This is shown in figure 2.

ECG on admission.

ECG 30 minutes after admission.

What would be the optimal management for this patient?

He was taken to the catheterization lab where the left anterior descending coronary artery (LAD) was shown to be completely occluded. Following successful percutaneous intervention and one drug eluding stent implantation in the LAD normal flow is restored (Thrombosis in myocardial infarction, TIMI = 3). 72 hours later, he is ready to be discharged home. The patient is keen to return to work and asks when he could do so.

When would you advise him that he could return to work?

One week later, he receives a letter informing him that he is required to attend cardiac rehabilitation. The patient is confused as to what cardiac rehabilitation entails, although he does remember a nurse discussing this with him briefly before he was discharged. He phones the hospital in order to get some more information.

Which of the following can be addressed during cardiac rehabilitation?

A - Acute coronary syndrome

Although the presentation could be attributable to any of the above differential diagnoses, the most likely etiology given the clinical picture and risk factors is one of cardiac ischemia. Risk factors include gender, smoking status and age making the diagnosis of acute coronary syndrome the most likely one. The broad differential diagnosis in patients presenting with chest pain has been discussed extensively in the medical literature. An old but relevant review can be found freely available 1 as well as more recent reviews. 2 , 3

C - Atorvastatin 80 mg, Clopidogrel 300 mcg, GTN 500 mcg, Ramipril 2.5 mg,

In patients with ACS, medications can be tailored to the individual patient. Some medications have symptomatic benefit but some also have prognostic benefit. Aspirin 4 , Clopidogrel 5 , Atenolol 6 and Atorvastatin 7 have been found to improve prognosis significantly. ACE inhibitors have also been found to improve left ventricular modeling and function after an MI. 8 , 9 Furthermore, GTN 10 and morphine 11 have been found to be of only significant symptomatic benefit.

Oxygen should only to be used when saturations <95% and at the lowest concentration required to keep saturations >95%. 12

There is no evidence that diltiazem, a calcium channel blocker, is of benefit. 13

His ECG in figure 1 does not fulfil ST elevation myocardial infarction (STEMI) criteria and he should therefore be managed as a Non-STEMI. He would benefit prognostically from beta-blockade however his heart rate is only 42 bpm and therefore this is contraindicated. He should receive a loading dose of clopidogrel (300 mg) followed by daily maintenance dose (75 mg). 14 , 15 He might not require GTN if he is pain-free but out of the available answers 3 is the most correct.

D - Proceed to coronary angiography

The ECG shows ST elevation in leads V2-V6 and confirms an anterolateral STEMI, which suggests a completely occluded LAD. This ECG fulfils the criteria to initiate reperfusion therapy which traditionally require one of the three to be present: According to guidance, if the patient can undergo coronary angiography within 120 minutes from the onset of chest pain, then this represents the optimal management. If it is not possible to undergo coronary angiography and potentially percutaneous intervention within 2 hours, then thrombolysis is considered an acceptable alternative. 12 , 16

≥ 1 mm of ST change in at least two contiguous limb leads (II, III, AVF, I, AVL).

≥ 2 mm of ST change in at least two contiguous chest leads (V1-V6).

New left bundle branch block.

GTN and morphine administration can be considered in parallel but they do not have a prognostic benefit.

E - Not before an exercise test

This patient is a lorry driver and therefore has a professional heavy vehicle driving license. The regulation for driving initiation in a lorry driver following a NSTEMI/ STEMI may be different in various countries and therefore the local regulations should be followed.

In the UK, a lorry driver holds a category 2 driving license. He should therefore refrain from driving a lorry for at least 6 weeks and can only return to driving if he completes successfully an exercise evaluation. An exercise evaluation is performed on a bicycle or treadmill. Drivers should be able to complete 3 stages of the standard Bruce protocol 17 or equivalent (e.g. Myocardial perfusion scan) safely, having refrained from taking anti-anginal medication for 48 hours and should remain free from signs of cardiovascular dysfunction during the test, notably: angina pectoris, syncope, hypotension, sustained ventricular tachycardia, and/or electrocardiographic ST segment shift which is considered as being indicative of myocardial ischemia (usually >2 mm horizontal or down-sloping) during exercise or the recovery period. 18

For a standard car driving license (category 1), driving can resume one week after successful intervention providing that no other revascularization is planned within 4 weeks; left ventricular ejection fraction (LVEF) is at least 40% prior to hospital discharge and there is no other disqualifying condition.

Therefore if this patent was in the UK, he could restart driving a normal car one week later assuming an echocardiogram confirmed an EF > 40%. However, he could only continue lorry driving once he has passed the required tests. 18

E - All of the above

Cardiac rehabilitation bridges the gap between hospitals and patients' homes. The cardiac rehabilitation team consists of various healthcare professions and the programme is started during hospital admission or after diagnosis. Its aim is to educate patients about their cardiac condition in order to help them adopt a healthier lifestyle. This includes educating patients' about their diet, exercise, risk factors associated with their condition such as smoking and alcohol intake and finally, about the medication recommended. There is good evidence that adherence to cardiac rehabilitation programmes improves survival and leads to a reduction in future cardiovascular events.​ 19 , 20

Oille JA . Differential diagnosis of pain in the chest . Can Med Assoc J . 1937 ; 37 (3) : 209 – 216 . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC536075/ .

Google Scholar

Lee TH , Goldman L . Evaluation of the patient with acute chest pain . N Engl J Med . 2000 ; 342 (16) : 1187 – 1195 . http://www.nejm.org/doi/full/10.1056/NEJM200004203421607 .

Douglas PS , Ginsburg GS . The evaluation of chest pain in women . N Engl J Med . 1996 ; 334 (20) : 1311 – 1315 . http://www.nejm.org/doi/full/10.1056/NEJM199605163342007 .

Baigent C , Collins R , Appleby P , Parish S , Sleight P , Peto R . ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. the ISIS-2 (second international study of infarct survival) collaborative group . BMJ . 1998 ; 316 (7141) : 1337 – 1343 . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC28530/ .

Yusuf S , Zhao F , Mehta S , Chrolavicius S , Tognoni G , Fox K . Clopidogrel in unstable angina to prevent recurrent events trail investigators . effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation . N Engl J Med . 2001 ; 345 (7) : 494 – 502 . http://www.nejm.org/doi/full/10.1056/NEJMoa010746#t=articleTop .

Yusuf S , Peto R , Lewis J , Collins R , Sleight P . Beta blockade during and after myocardial infarction: An overview of the randomized trials . Prog Cardiovasc Dis . 1985 ; 27 (5) : 335 – 371 . http://www.sciencedirect.com/science/article/pii/S0033062085800037 .

Schwartz GG , Olsson AG , Ezekowitz MD et al.  . Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial . JAMA . 2001 ; 285 (13) : 1711 – 1718 . http://jama.jamanetwork.com/article.aspx?articleid=193709 .

Pfeffer MA , Lamas GA , Vaughan DE , Parisi AF , Braunwald E . Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction . N Engl J Med . 1988 ; 319 (2) : 80 – 86 . http://content.onlinejacc.org/article.aspx?articleid=1118054 .

Sharpe N , Smith H , Murphy J , Hannan S . Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction . The Lancet . 1988 ; 331 (8580) : 255 – 259 . http://www.sciencedirect.com/science/article/pii/S0140673688903479 .

Ferreira JC , Mochly-Rosen D . Nitroglycerin use in myocardial infarction patients . Circ J . 2012 ; 76 (1) : 15 – 21 . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527093/ .

Herlitz J , Hjalmarson A , Waagstein F . Treatment of pain in acute myocardial infarction . Br Heart J . 1989 ; 61 (1) : 9 – 13 . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1216614/ .

Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al . ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation . Eur Heart J . 2012 ; 33 (20) : 2569 – 2619 . http://eurheartj.oxfordjournals.org/content/33/20/2569 .

The effect of diltiazem on mortality and reinfarction after myocardial infarction . the multicenter diltiazem postinfarction trial research group . N Engl J Med . 1988 ; 319 (7) : 385 – 392 . http://www.nejm.org/doi/full/10.1056/NEJM198808183190701 .

Jneid H , Anderson JL , Wright RS et al.  . 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non–ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update) A report of the american college of cardiology foundation/american heart association task force on practice guidelines . J Am Coll Cardiol . 2012 ; 60 (7) : 645 – 681 . http://circ.ahajournals.org/content/123/18/2022.full .

Hamm CW , Bassand JP , Agewall S et al.  . ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC) . Eur Heart J . 2011 ; 32 (23) : 2999 – 3054 . http://eurheartj.oxfordjournals.org/content/32/23/2999.long .

O'Gara PT , Kushner FG , Ascheim DD et al.  . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the american college of cardiology foundation/american heart association task force on practice guidelines . J Am Coll Cardiol . 2013 ; 61 (4) : 485 – 510 . http://content.onlinejacc.org/article.aspx?articleid=1486115 .

BRUCE RA , LOVEJOY FW Jr . Normal respiratory and circulatory pathways of adaptation in exercise . J Clin Invest . 1949 ; 28 (6 Pt 2) : 1423 – 1430 . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC439698/ .

DVLA . Https://Www.gov.uk/current-medical-guidelines-dvla-guidance-for-professionals-cardiovascular-chapter-appendix .

British Heart Foundation . Http://Www.bhf.org.uk/heart-health/living-with-heart-disease/cardiac-rehabilitation.aspx .

Kwan G , Balady GJ . Cardiac rehabilitation 2012: Advancing the field through emerging science . Circulation . 2012 ; 125 (7) : e369–73. http://circ.ahajournals.org/content/125/7/e369.full .

Author notes

• knowledge acquisition

Email alerts

Citing articles via, affiliations.

• Online ISSN 2053-8855
• Copyright © 2024 Oxford University Press
• About Oxford Academic
• Publish journals with us
• University press partners
• What we publish
• New features  
• Open access
• Institutional account management
• Rights and permissions
• Get help with access
• Accessibility
• Advertising
• Media enquiries
• Oxford University Press
• Oxford Languages
• University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

• Copyright © 2024 Oxford University Press
• Cookie settings
• Cookie policy
• Privacy policy
• Legal notice

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Want to create or adapt books like this? Learn more about how Pressbooks supports open publishing practices.

Mr. Bob Carlson is a 59 year old male who came to Ventura County Medical Center (VCMC) with nausea, upper back pain he rated 7/10, and diaphoretic. His vital signs were BP 156/92, HR 90, RR 22 SpO2 90%, and temperature 99.5. Physical examination revealed clear lung sounds, mild tachypnea, S1 S2 present, and several ulcerations to the right foot. Ordes were  given to obtain a 12-lead ECG and labs (CBC, CMP, Coagulations, Cardiac Enzymes, and Lipid Profile). In addition orders were given to start Mr. Carlson on 2L oxygen via nasal cannula and obtain venous access. A 20 gauge IV was started in his left AC.

Mr. Carlson’s medical history revealed that he is a type II diabetic, has hypertension, hyperlipidemia, and smokes 1/2 pack of cigarettes a day for the past 40 years. His diabetes is poorly managed and Mr.Carlson had a left below the knee amputation 2 years ago due to diabetic ulcers that were gangrenous. In addition, Mr. Carlson has a history of IV drug use but now receives a daily dose (90 mg) of Methadone at a local clinic. He is divorced, no children and is currently living with his 85 year old mother.

Mr. Carlson’s ECG results showed ST-segment elevation in leads II, III, and aVf and in V4, V5 and V6 with ST-segment depression V1, V2, and V3. The provider identified this to be an MI occurring in the inferior portion of the heart, likely affecting his right coronary artery (RCA). Lab results confirmed a ST-segment elevation MI (Troponin-I 12.9, CK 520, and CKMB 25.2). A code STEMI was called and Mr. Carlson was immediately prepared for a Percutaneous coronary intervention (PCI). While waiting for transfer to the Catheterization Lab at Community Memorial Hospital (CMH) Mr. Carlson was given 325 mg of Aspirin, 2 mg Morphine, and was started on a 5000 unit bolus of Heparin. Nitroglycerin was not given due to the profound hypotension associated with nitroglycerin and patients experiencing an inferior myocardial infarction.

Mr. Carlson was transferred to the CMH catheterization lab. His vitals were stable and he was able to give informed consent. The cardiac angiography showed a 95% occlusion to the RCA. A stent was placed, the patient tolerated the procedure well. The patient’s right femoral artery was closed successfully with manual pressure.

Mr. Carlson returned to the cardiac care unit where upon assessment his groin was found to be soft and without hepatoma and with minimal drainage from incision site. His peripheral pulses were present, and distal to the incision his skin was warm with capillary refill less than 2 seconds. Mr. Carlson was transferred back to VCMC the following day were he recovered without further incident.

Before discharge Mr. Carlson’s was educated on his new prescriptions and was educated on the importance of taking his daily aspirin. He met with the diabetes educator, dietician, and social worker before discharge. Mr. Carlson was informed of smoking cessation programs in the area but declined to enroll. Case Management found placement in a skilled nursing facility for 20 days, the amount of days 100% covered by Medi-Cal, where he could start a cardiac rehabilitation program. A home health organization was organized to help provide care for Mr. Carlson when he returned to his home.

• What medications do you anticipate Mr. Carlson being prescribed upon discharge?  Aspirin, ACE-I or ARB, beta blocker, and a statin
• What nursing interventions are critical prior to the patient being taken to the cath lab?  -Assess the client’s and family’s knowledge and understanding of the procedure. – Provide routine preoperative care as ordered. Signed consent is required and maintain patient NPO. -Assess for hypersensitivity to iodine, radiologic contrast media, or seafood. An iodine-based radiologic contrast dye is typically used for angiogram. Iodine or seafood allergy increases the risk for anaphylaxis and requires an alternative dye or special precautions. -Record baseline assessment data, including vital signs, height, and weight. Mark the locations of peripheral pulses; document their equality and amplitude. 
• Which risk factors may have contributed to Mr. Carlson’s myocardial infarction?  Hyperlipidemia, uncontrolled diabetes, smoking, inactivity, drug use, and diet. 

Nursing Case Studies by and for Student Nurses Copyright © by jaimehannans is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License , except where otherwise noted.

Share This Book

Myocardial Infarction (MI) Case Study (45 min)

Watch More! Unlock the full videos with a FREE trial

Included In This Lesson

Study tools.

Access More! View the full outline and transcript with a FREE trial

Definition of Myocardial Infarction (MI)

Myocardial infarction, commonly known as a heart attack, is a critical medical event that occurs when the blood supply to the heart muscle is severely reduced or completely blocked. It is a leading cause of death worldwide and a significant public health concern.

Introduction to Myocardial Infarction (MI)

This nursing case study aims to provide a comprehensive understanding of myocardial infarction by delving into its various aspects, including its pathophysiology, risk factors, clinical presentation, diagnostic methods, and management strategies. Through the exploration of a fictional patient’s journey, we will shed light on the intricate nature of this life-threatening condition and highlight the importance of early recognition and intervention.

Background and Significance of Myocardial Infarction

Myocardial infarction is a sudden and often catastrophic event that can have profound consequences on an individual’s health and well-being. Understanding its underlying mechanisms and risk factors is essential for healthcare professionals, as timely intervention can be life-saving. This case study not only serves as a learning tool but also emphasizes the critical role of medical practitioners in identifying and managing myocardial infarctions promptly.

Pathophysiology of Myocardial Infarction

A crucial aspect of comprehending myocardial infarction is exploring its pathophysiology. We will delve into the intricate details of how atherosclerosis, the buildup of plaque in coronary arteries, leads to the formation of blood clots and the subsequent interruption of blood flow to the heart muscle. This disruption in blood supply triggers a cascade of events, ultimately resulting in the death of cardiac cells.

Risk Factors of Myocardial Infarction

Understanding the risk factors associated with myocardial infarction is vital for prevention and early detection. This case study will examine both modifiable and non-modifiable risk factors, including age, gender, family history, smoking, high blood pressure, diabetes, and high cholesterol levels. Recognizing these risk factors is instrumental in developing effective strategies for prevention and risk reduction.

Clinical Presentation Myocardial Infarction

Recognizing the signs and symptoms of myocardial infarction is crucial for timely intervention. We will present a fictional patient’s experience, illustrating the typical clinical presentation, which often includes chest pain or discomfort, shortness of breath, nausea, lightheadedness, and diaphoresis. Through this patient’s journey, we will highlight the importance of accurate symptom assessment and prompt medical attention.

Diagnostic Methods for Myocardial Infarction

Modern medicine offers various diagnostic tools to confirm a myocardial infarction swiftly and accurately. This case study will explore these diagnostic methods, such as electrocardiography (ECG), cardiac biomarkers, and imaging techniques like coronary angiography. By understanding these diagnostic modalities, healthcare professionals can make informed decisions and initiate appropriate treatments promptly.

Management Strategies for Myocardial Infarction

The management of myocardial infarction involves a multidisciplinary approach, including medication, revascularization procedures, and lifestyle modifications. We will discuss the fictional patient’s treatment plan, emphasizing the importance of reestablishing blood flow to the affected heart muscle and preventing further complications.

Nursing Case Study for Myocardial Infarction (MI)

Having established a foundational understanding of myocardial infarction, we will now delve deeper into Mr. Salazar’s case, tracing his journey through diagnosis, treatment, and recovery. This in-depth examination will shed light on the real-world application of the principles discussed in the introduction, providing valuable insights into the clinical management of myocardial infarction and its impact on patient outcomes.

Mr. Salazar, a 57-year-old male, arrives at the Emergency Department (ED) with complaints of chest pain that began approximately one hour after dinner while he was working. He characterizes the discomfort as an intense “crushing pressure” located centrally in his chest, extending down his left arm and towards his back. He rates the pain’s severity as 4/10. Upon examination, Mr. Salazar exhibits diaphoresis and pallor, accompanied by shortness of breath (SOB).

What further nursing assessments need to be performed for Mr. Salazar?

• Heart Rate (HR): The number of heartbeats per minute.
• Blood Pressure (BP): The force of blood against the walls of the arteries, typically measured as systolic (during heartbeats) and diastolic (between heartbeats) pressure.
• Respiratory Rate (RR): The number of breaths a patient takes per minute.
• Body Temperature (Temp): The measurement of a patient’s internal body heat.
• Oxygen Saturation (SpO2): The percentage of oxygen in the blood.
• S1: The first heart sound, often described as “lub,” is caused by the closure of the mitral and tricuspid valves.
• S2: The second heart sound, known as “dub,” results from the closure of the aortic and pulmonic valves.
• These sounds provide important diagnostic information about the condition of the heart.
• Clear: Normal, healthy lung sounds with no added sounds.
• Crackles (Rales): Discontinuous, often high-pitched sounds are heard with conditions like pneumonia or heart failure.
• Wheezes: Whistling, musical sounds often associated with conditions like asthma or chronic obstructive pulmonary disease (COPD).
• Pulses refer to the rhythmic expansion and contraction of arteries with each heartbeat. Common pulse points for assessment include the radial artery (wrist), carotid artery (neck), and femoral artery (groin). Evaluating pulses helps assess the strength, regularity, and rate of blood flow.
• Edema is the abnormal accumulation of fluid in body tissues, leading to swelling. It can occur in various body parts and may indicate underlying conditions such as heart failure, kidney disease, or localized injury. Edema assessment involves evaluating the degree of swelling and its location.
• Skin condition (temperature, color, etc.)

What interventions do you anticipate being ordered by the provider?

• Oxygen therapy involves administering oxygen to a patient to increase the level of oxygen in their blood. It is used to treat conditions such as respiratory distress, and hypoxia (low oxygen levels), and to support patients with breathing difficulties.
• Nitroglycerin is a medication used to treat angina (chest pain) and to relieve symptoms of heart-related conditions. It works by relaxing and widening blood vessels, which improves blood flow to the heart, reducing chest pain.
• Aspirin is a common over-the-counter medication and antiplatelet drug. In the context of myocardial infarction (heart attack), it is often administered to reduce blood clot formation, potentially preventing further blockage in coronary arteries.
• A 12-lead EKG is a diagnostic test that records the electrical activity of the heart from 12 different angles. It provides information about the heart’s rhythm, rate, and any abnormalities, helping diagnose conditions like arrhythmias, heart attacks, and ischemia.
• Cardiac enzymes are proteins released into the bloodstream when heart muscle cells are damaged or die, typically during a heart attack. Measuring these enzymes, such as troponin and creatine kinase-MB (CK-MB), helps confirm a heart attack diagnosis and assess its severity.
• A chest X-ray is a diagnostic imaging procedure that creates images of the chest and its internal structures, including the heart and lungs. It is used to identify issues like lung infections, heart enlargement, fluid accumulation, or fractures in the chest area.
• Possibly an Echocardiogram

Upon conducting a comprehensive assessment, it was observed that the patient exhibited no signs of jugular vein distention (JVD) or edema. Auscultation revealed normal heart sounds with both S1 and S2 present, while the lungs remained clear, albeit with scattered wheezes. The patient’s vital signs were recorded as follows:

• BP 140/90 mmHg SpO 2 90% on Room Air
• HR 92 bpm and regular Ht 173 cm
• RR 32 bpm Wt 104 kg
• Temp 36.9°C

The 12-lead EKG repor t indicated the presence of “Normal sinus rhythm (NSR) with frequent premature ventricular contractions (PVCs) and three- to four-beat runs of ventricular tachycardia (VT).” Additionally, there was ST-segment elevation in leads I, aVL, and V2 through V6 (3-4mm), accompanied by ST-segment depression in leads III and aVF.

Cardiac enzyme levels were collected but were awaiting results at the time of assessment. A chest x-ray was also ordered to provide further diagnostic insights.

In response to the patient’s condition, the healthcare provider prescribed the following interventions:

• Aspirin: 324 mg administered orally once.
• Nitroglycerin: 0.4 mg administered sublingually (SL), with the option of repeating the dose every five minutes for a maximum of three doses.
• Morphine: 4 mg to be administered intravenously (IVP) as needed for unrelieved chest pain.
• Oxygen: To maintain oxygen saturation (SpO2) levels above 92%.

These interventions were implemented to address the patient’s myocardial infarction (heart attack) and alleviate associated symptoms, with a focus on relieving chest pain, improving oxygenation, and closely monitoring vital signs pending further diagnostic results.

What intervention should you, as the nurse, perform right away? Why?

• Apply oxygen – this can be done quickly and easily and can help to prevent further complications from low oxygenation.
• Oxygen helps to improve oxygenation as well as to decrease myocardial oxygen demands.
• Often it takes a few minutes or more for medications to be available from the pharmacy, so it makes sense to take care of this intervention first.
• ABC’s – breathing/O 2 .

What medication should be the first one administered to this patient? Why? How often?

• Nitroglycerin 0.4mg SL – it is a vasodilator and works on the coronary arteries. The goal is to increase blood flow to the myocardium. If this is effective, the patient merely has angina. However, if it is not effective, the patient may have a myocardial infarction.
• Aspirin should also be given, but it is to decrease platelet aggregation and reduce mortality. While it can somewhat help prevent the worsening of the blockage, it does little for the current pain experienced by the patient.
• Morphine should only be given if the nitroglycerin and aspirin do not relieve the patient’s chest pain.

What is the significance of the ST-segment changes on Mr. Salazar's 12-lead EKG?

• ST-segment changes on a 12-lead EKG indicate ischemia (lack of oxygen/blood flow) or infarction (death of the muscle tissue) of the myocardium (heart muscle). 
• This indicates an emergent situation. The patient’s coronary arteries are blocked and need to be reopened by pharmacological (thrombolytic) or surgical (PCI) intervention.
• Time is tissue – the longer the coronary arteries stay blocked, the more of the patient’s myocardium that will die. Dead heart tissue doesn’t beat.

Mr. Salazar’s chest pain was unrelieved after three (3) doses of sublingual nitroglycerin (NTG). Morphine 5 mg intravenous push (IVP) was administered, as well as 324 mg chewable baby aspirin. His pain was still unrelieved at this point

Mr. Salazar’s cardiac enzyme results were as follows:

Troponin I 3.5 ng/mL

Based on the results of Mr. Salazar's labs and his response to medications, what is the next intervention you anticipate? Why?

• Mr. Salazar needs intervention. He will either receive thrombolytics or a heart catheterization (PCI).
• Based on the EKG changes, elevated Troponin level, and the fact that his symptoms are not subsiding, it’s possible the patient has a significant blockage in one or more of his coronary arteries. 
• It seems as though it may be an Anterior-Lateral MI because ST elevation is occurring in I, aVL, and V 2 -V 6 .

Mr. Salazar was taken immediately to the cath lab for a Percutaneous Coronary Intervention (PCI). The cardiologist found a 90% blockage in his left anterior descending (LAD) artery. A stent was inserted to keep the vessel open.

What is the purpose of Percutaneous Coronary Intervention (PCI), also known as a heart catheterization?

• A PCI serves to open up any coronary arteries that are blocked. First, they use contrast dye to determine where the blockage is, then they use a special balloon catheter to open the blocked vessels. 
• If that doesn’t work, they will place a cardiac stent in the vessel to keep it open.[ /faq]

[faq lesson="true" blooms="Application" question="What is the expected outcome of a PCI? What do you expect to see in your patient after they receive a heart catheterization?"]

• Blood flow will be restored to the myocardium with minimal residual damage.
• The patient should have baseline vital signs, relief of chest pain, normal oxygenation status, and absence of heart failure symptoms (above baseline).
• The patient should be able to ambulate without significant chest pain or SOB.
• The patient should be free from bleeding or hematoma at the site of catheterization (often femoral, but can also be radial or (rarely) carotid.

Mr. Salazar tolerated the PCI well and was admitted to the cardiac telemetry unit for observation overnight. Four (4) hours after the procedure, Mr. Salazar reports no chest pain. His vital signs are now as follows:

• BP 128/82 mmHg SpO 2 96% on 2L NC
• HR 76 bpm and regular RR 18 bpm
• Temp 37.1°C

Mr. Salazar will be discharged home 24 hours after his arrival to the ED and will follow up with his cardiologist next week. 

What patient education topics would need to be covered with Mr. Salazar?

• He should be taught any dietary and lifestyle changes that should be made.
• Diet – low sodium, low cholesterol, avoid sugar/soda, avoid fried/processed foods.
• Exercise – 30-45 minutes of moderate activity 5-7 days a week, u nless instructed otherwise by a cardiologist. This will be determined by the patient’s activity tolerance – how much can they do and still be able to breathe and be pain-free?
• Stop smoking and avoid caffeine and alcohol.
• Medication Instructions
• Nitroglycerin – take one SL tab at the onset of chest pain. If the pain does not subside after 5 minutes, call 911 and take a second dose. You can take a 3rd dose 5 minutes after the second if the pain does not subside. Do NOT take if you have taken Viagra in the last 24 hours.
• Aspirin – take 81 mg of baby aspirin daily
• Anticoagulant – the patient may be prescribed an anticoagulant if they had a stent placed.  They should be taught about bleeding risks.
• When to call the provider – CP unrelieved by nitroglycerin after 5 minutes. Syncope. Evidence of bleeding in stool or urine (if on anticoagulant). Palpitations, shortness of breath, or difficulty tolerating activities of daily living.

Linchpins for Myocardial Infarction Nursing Case Study

In summary, Mr. Salazar’s case highlights the urgency of recognizing and responding to myocardial infarction promptly. The application of vital signs, EKG, cardiac enzymes, and medications like aspirin, nitroglycerin, and morphine played a pivotal role in his care. Diagnostic tools like echocardiography and chest X-rays contributed to a comprehensive evaluation.

Nurses must remain vigilant and compassionate in such emergencies. This case study emphasizes the importance of adhering to best practices in the assessment, diagnosis, and management of myocardial infarction, with the ultimate goal of achieving favorable patient outcomes.

View the FULL Outline

When you start a FREE trial you gain access to the full outline as well as:

• SIMCLEX (NCLEX Simulator)
• 6,500+ Practice NCLEX Questions
• 2,000+ HD Videos
• 300+ Nursing Cheatsheets

“Would suggest to all nursing students . . . Guaranteed to ease the stress!”

Nursing Case Studies

This nursing case study course is designed to help nursing students build critical thinking.  Each case study was written by experienced nurses with first hand knowledge of the “real-world” disease process.  To help you increase your nursing clinical judgement (critical thinking), each unfolding nursing case study includes answers laid out by Blooms Taxonomy  to help you see that you are progressing to clinical analysis.We encourage you to read the case study and really through the “critical thinking checks” as this is where the real learning occurs.  If you get tripped up by a specific question, no worries, just dig into an associated lesson on the topic and reinforce your understanding.  In the end, that is what nursing case studies are all about – growing in your clinical judgement.

Nursing Case Studies Introduction

Cardiac nursing case studies.

• 6 Questions
• 7 Questions
• 5 Questions
• 4 Questions

GI/GU Nursing Case Studies

• 2 Questions
• 8 Questions

Obstetrics Nursing Case Studies

Respiratory nursing case studies.

• 10 Questions

Pediatrics Nursing Case Studies

• 3 Questions
• 12 Questions

Neuro Nursing Case Studies

Mental health nursing case studies.

• 9 Questions

Metabolic/Endocrine Nursing Case Studies

Other nursing case studies.

Enhanced ECG Signal features transformation to RGB matrix imaging for advanced deep learning classification of myocardial infarction and cardiac arrhythmia

• Published: 13 May 2024

Cite this article

• Zakaria Khatar   ORCID: orcid.org/0000-0002-3466-9613 1   na1 &
• Dounia Bentaleb 2   na1  

Identifying and accurately classifying cardiac abnormalities, including myocardial infarction (MI) and cardiac arrhythmia (CA), remains a significant challenge in the field of cardiology, largely due to the limitations inherent in traditional ECG signal analysis techniques. This paper presents an innovative method aimed at addressing this challenge. By implementing a novel transformation technique, we map temporal, frequency-based, statistical, and spatial features of ECG signals onto the R, G, and B channels of an RGB image. This conversion process results in a feature-rich representation of the ECG signal, significantly enhancing its clinical relevance and thus maximizing classification accuracy. Utilizing an adaptive RGB-ResNet inception architecture, our approach achieves remarkable average accuracies of 99.25% for myocardial infarction and 99.21% for cardiac arrhythmia. These figures underscore the robustness of our method and highlight its significant potential to advance cardiology diagnostics through the application of advanced image analysis techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Russian Federation)

Instant access to the full article PDF.

Rent this article via DeepDyve

Institutional subscriptions

Data Availability

The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ebrahimi Z, Loni M, Daneshtalab M, Gharehbaghi A (2020) A review on deep learning methods for ecg arrhythmia classification. Expert Syst Appl X 7:100033

Google Scholar  

Xiong P, Lee SM-Y, Chan G (2022) Deep learning for detecting and locating myocardial infarction by electrocardiogram: A literature review. Front Cardiovasc Med 9:860032

Article   Google Scholar  

Ansari Y, Mourad O, Qaraqe K, Serpedin E (2023) Deep learning for ecg arrhythmia detection and classification: an overview of progress for period 2017–2023. Front Physiol 14

Kuila S, Dhanda N, Joardar S (2022) Ecg signal classification and arrhythmia detection using elm-rnn. Multimed Tools Appl 81(18):25233–25249

Hammad M, Abd El-Latif AA, Hussain A, Abd El-Samie FE, Gupta BB, Ugail H, Sedik A (2022) Deep learning models for arrhythmia detection in iot healthcare applications. Comput Electr Eng 100:108011

Tao R, Wang L, Xiong Y, Zeng Y-R (2024) Im-ecg: An interpretable framework for arrhythmia detection using multi-lead ecg. Expert Syst Appl 237:121497

Shamaee Z, Mivehchy M (2023) Dominant noise-aided emd (demd): Extending empirical mode decomposition for noise reduction by incorporating dominant noise and deep classification. Biomed Signal Process Control 80:104218

Li Y, Luo J-h, Dai Q-y, Eshraghian JK, Ling BW-K, Zheng C-y, Wang X-l (2023) A deep learning approach to cardiovascular disease classification using empirical mode decomposition for ecg feature extraction. Biomed Signal Process Control 79:104188

Pan W, An Y, Guan Y, Wang J (2022) Mca-net: A multi-task channel attention network for myocardial infarction detection and location using 12-lead ecgs. Comput Biol Med 150:106199

Yu J, Gao J, Wang N, Feng P, Zhou B, Wang Z (2023) Spa-tem mi: A spatial-temporal network for detecting and locating myocardial infarction. IEEE Trans Instrum Meas

Mewada H (2023) 2d-wavelet encoded deep cnn for image-based ecg classification. Multimed Tools Appl 1–17

Koresh H (2024) Impact of the preprocessing steps in deep learning-based image classifications. Natl Acad Sci Lett 1:1–3

Singhal S, Kumar M (2024) Gsmd-srst: Group sparse mode decomposition and superlet transform based technique for multi-level classification of cardiac arrhythmia. IEEE Sens J

Wu W, Huang Y, Wu X (2024) Srt: Improved transformer-based model for classification of 2d heartbeat images. Biomed Signal Process Control 88:105017

Zhang P, Ma C, Sun Y, Fan G, Song F, Feng Y, Zhang G (2021) Global hybrid multi-scale convolutional network for accurate and robust detection of atrial fibrillation using single-lead ecg recordings. Comput Biol Med 139:104880

Prabhakararao E, Dandapat S (2021) Multi-scale convolutional neural network ensemble for multi-class arrhythmia classification. IEEE J Biomed Health Inform 26(8):3802–3812

Jahmunah V, Ng EYK, Tan R-S, Oh SL, Acharya UR (2022) Explainable detection of myocardial infarction using deep learning models with grad-cam technique on ecg signals. Comput Biol Med 146:105550

Balık MY, Gökçe K, Atmaca S, Aslanger E, Güler A, Öksüz İ (2023) Interpretable deep learning for myocardial infarction detection from ecg signals. In: 2023 31st Signal processing and communications applications conference (SIU), pp 1–4. IEEE

Adib E, Fernandez AS, Afghah F, Prevost JJ (2023) Synthetic ecg signal generation using probabilistic diffusion models. IEEE Access

Nahak S, Pathak A, Saha G (2023) Evaluation of handcrafted features and learned representations for the classification of arrhythmia and congestive heart failure in ecg. Biomed Signal Process Control 79:104230

Murat F, Yildirim O, Talo M, Demir Y, Tan R-S, Ciaccio EJ, Acharya UR (2021) Exploring deep features and ecg attributes to detect cardiac rhythm classes. Knowl-Based Syst 232:107473

Khatar Z, Bentaleb D, Bouattane O (2024) Advanced detection of cardiac arrhythmias using a three-stage cbd filter and a multi-scale approach in a combined deep learning model. Biomed Signal Process Control 88:105551

Xiao Q, Lee K, Mokhtar SA, Ismail I, Pauzi ALbM, Zhang Q, Lim PY (2023) Deep learning-based ecg arrhythmia classification: A systematic review. Appl Sci 13(8):4964

Chen Z, Yang D, Cui T, Li D, Liu H, Yang Y, Zhang S, Yang S, Ren T-L (2024) A novel imbalanced dataset mitigation method and ecg classification model based on combined 1d_cbam-autoencoder and lightweight cnn model. Biomed Signal Process Control 87:105437

Narotamo H, Dias M, Santos R, Carreiro AV, Gamboa H, Silveira M (2024) Deep learning for ecg classification: A comparative study of 1d and 2d representations and multimodal fusion approaches. Biomed Signal Process Control 93:106141

Nawaz M, Saleem S, Masood M, Rashid J, Nazir T (2024) Covid-ecg-rsnet: Covid-19 classification from ecg images using swish-based improved resnet model. Biomed Signal Process Control 89:105801

Hammad AH, Abdulbaqi, AS (2024) 2d ecg classification system based on machine learning and lbp. In: AIP conference proceedings, vol 3009. AIP Publishing

Admass WS, Bogale GA (2024) Arrhythmia classification using ecg signal: A meta-heuristic improvement of optimal weighted feature integration and attention-based hybrid deep learning model. Biomed Signal Process Control 87:105565

Sheikh D, Verma H, Chauhan N (2024) Reduced lead ecg multi-label classification with higher generalization using 2d seresnets with self attention. Multimed Tools Appl 1–25

Sharma P, Dinkar SK (2024) An intelligent deep neural network with opposition based laplacian equilibrium optimizer to improve feature extraction using ecg signals. Biomed Signal Process Control 87:105415

Borra SR, Nayana DRGA, Srinidhi S, Bhavana S, Nishitha P, Sahithi V (2024) Cadnet: cardiac arrhythmia detection and classification using unified principal component analysis and 1d-cnn model. Res Biomed Eng 1–13

Wajgi R, Brammya G, Ramesh G, Deotare VV, Govindasamy C, Preetha NN (2024) A novel enhanced lemurs optimization-based hybrid attention network for classifying arrthymia from ecg signal using optimal weighted feature. Aust J Electr Electron Eng 1:1–25

Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng C-K, Stanley HE (2000) Physiobank, physiotoolkit, and physionet: components of a new research resource for complex physiologic signals. Circulation 101 23:215–220

Goldberger A, Amaral L, Glass L, Hausdorff J, Ivanov P, Mark R, Mietus J, Moody G, Peng C, Stanley H (2000) The MIT-BIH Arrhythmia Database. PhysioBank, MIT. https://physionet.org/content/mitdb/1.0.0/

Alotaibi B, Alotaibi M (2020) A hybrid deep resnet and inception model for hyperspectral image classification. PFG - J Photogramm Remote Sens Geoinf Sci 88(6):463–476

Szegedy C, Ioffe S, Vanhoucke V, Alemi A (2017) Inception-v4, inception-resnet and the impact of residual connections on learning. In: Proceedings of the AAAI conference on artificial intelligence, vol 31

Brown LD, Cai TT, DasGupta A (2001) Interval estimation for a binomial proportion. Stat Sci 16(2):101–133

Article   MathSciNet   Google Scholar  

Agresti A, Coull BA (1998) Approximate is better than “exact’’ for interval estimation of binomial proportions. Am Stat 52(2):119–126

MathSciNet   Google Scholar  

Moghadam SR, Asl BM (2023) Automatic diagnosis and localization of myocardial infarction using morphological features of ecg signal. Biomed Signal Process Control 83:104671

Singh VM, Saran V, Kadambi P (2023) Autonomous myocardial infarction detection from electrocardiogram with a multi label classification approach. In: Asian conference on machine learning, pp 911–926. PMLR

Nagaraj J, Leema A (2023) Light weight multi-branch network-based extraction and classification of myocardial infarction from 12 lead electrocardiogram images. Imaging Sci J 71(2):188–198

Mandala S, Amini SS, Syaifullah AR, Pramudyo M, Nurmaini S, Abdullah AH et al (2023) Enhanced myocardial infarction identification in phonocardiogram signals using segmented feature extraction and transfer learning-based classification. IEEE Access 11:136654–136665

Sadad T, Safran M, Khan I, Alfarhood S, Khan R, Ashraf I (2023) Efficient classification of ecg images using a lightweight cnn with attention module and iot. Sensors 23(18):7697

Attallah O, Ragab DA (2023) Auto-myin: Automatic diagnosis of myocardial infarction via multiple glcms, cnns, and svms. Biomed Signal Process Control 80:104273

Aziz S, Khan MU, Iqtidar K, Sharma S, Montes GA, Gareeballah A (2023) Detection of myocardial infarction using spectral textures through ecg. In: 2023 International conference on communication, computing and digital systems (C-CODE), pp 1–6. IEEE

Mandala S, et al (2023) Myocardial infarction detection as an element of preventive medicine with random forest. In: 2023 International conference on advancement in data science, e-learning and information system (ICADEIS), pp 1–5. IEEE

Rawal V, Prajapati P, Darji A (2023) Hardware implementation of 1d-cnn architecture for ecg arrhythmia classification. Biomed Signal Process Control 85:104865

Kumar A, Kumar SA, Dutt V, Shitharth S, Tripathi E (2023) Iot based arrhythmia classification using the enhanced hunt optimization-based deep learning. Expert Syst 40(7):13298

Reddy SD, Murugan R, Nandi A, Goel T (2023) Classification of arrhythmia disease through electrocardiogram signals using sampling vector random forest classifier. Multimed Tools Appl 82(17):26797–26827

Serhal H, Abdallah N, Marion J-M, Chauvet P, Oueidat M, Humeau-Heurtier A (2023) An emd-based approach for atrial fibrillation classification using wavelets and convolutional neural network. Biomed Signal Process Control 82:104507

Pham B-T, Le PT, Tai T-C, Hsu Y-C, Li Y-H, Wang J-C (2023) Electrocardiogram heartbeat classification for arrhythmias and myocardial infarction. Sensors 23(6):2993

Zhang Y, Yi J, Chen A, Cheng L (2023) Cardiac arrhythmia classification by time-frequency features inputted to the designed convolutional neural networks. Biomed Signal Process Control 79:104224

Wang Y, Yang G, Li S, Li Y, He L, Liu D (2023) Arrhythmia classification algorithm based on multi-head self-attention mechanism. Biomed Signal Process Control 79:104206

Karri M, Annavarapu CSR, Pedapenki KK (2023) A real-time cardiac arrhythmia classification using hybrid combination of delta modulation, 1d-cnn and blended lstm. Neural Process Lett 55(2):1499–1526

Download references

Author information

Zakaria Khatar and Dounia Bentaleb are both contributed equally to this work.

Authors and Affiliations

Superior School of Technical Education, University Hassan II, Mohammedia, Morocco

Zakaria Khatar

Faculty of Science Techniques, University Hassan II, Mohammedia, Morocco

Dounia Bentaleb

You can also search for this author in PubMed   Google Scholar

Corresponding author

Correspondence to Zakaria Khatar .

Ethics declarations

Competing interest.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher's note.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Khatar, Z., Bentaleb, D. Enhanced ECG Signal features transformation to RGB matrix imaging for advanced deep learning classification of myocardial infarction and cardiac arrhythmia. Multimed Tools Appl (2024). https://doi.org/10.1007/s11042-024-19352-z

Download citation

Received : 27 November 2023

Revised : 05 April 2024

Accepted : 30 April 2024

Published : 13 May 2024

DOI : https://doi.org/10.1007/s11042-024-19352-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Myocardial infarction classification
• Cardiac arrhythmia classification
• ECG signal transformation into RGB imaging
• RGB resnet-inception neural network
• Deep learning with RGB data

Advertisement

• Find a journal
• Publish with us
• Track your research

An official website of the United States government

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings
• Browse Titles

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

StatPearls [Internet].

Myocardial infarction (nursing).

Niranjan Ojha ; Amit S. Dhamoon ; Rojeena Chapagain .

Affiliations

Last Update: August 8, 2023 .

• Learning Outcome
• Recall the risk factors for ischemic heart disease
• Describe the presentation of acute myocardial infarction (MI)
• Summarize the treatment of an acute MI
• List the nursing management roles of a patient with an acute MI
• Introduction

Myocardial infarction (MI), colloquially known as “heart attack,” is caused by decreased or complete cessation of blood flow to a portion of the myocardium. Myocardial infarction may be “silent” and go undetected, or it could be a catastrophic event leading to hemodynamic deterioration and sudden death. [1] Most myocardial infarctions are due to underlying coronary artery disease, the leading cause of death in the United States. With coronary artery occlusion, the myocardium is deprived of oxygen. Prolonged deprivation of oxygen supply to the myocardium can lead to myocardial cell death and necrosis. [2]  Patients can present with chest discomfort or pressure that can radiate to the neck, jaw, shoulder, or arm. In addition to the history and physical exam, myocardial ischemia may be associated with ECG changes and elevated biochemical markers such as cardiac troponins. [3] [4]

• Nursing Diagnosis
• Difficulty breathing
• Poor tissue perfusion
• Unable to perform activities

As stated above, myocardial infarction is closely associated with coronary artery disease. INTERHEART is an international multi-center case-control study which delineated the following modifiable risk factors for coronary artery disease: [5]   [6]

• Abnormal lipid profile/blood apolipoprotein (raised ApoB/ApoA1)
• Hypertension
• Diabetes mellitus
• Abdominal obesity (waist/hip ratio) (greater than 0.90 for males and greater than 0.85 for females)
• Psychosocial factors such as depression, loss of the locus of control, global stress, financial stress, and life events including marital separation, job loss, and family conflicts
• Lack of daily consumption of fruits or vegetables
• Lack of physical activity
• Alcohol consumption (weaker association, protective)

The INTERHEART study showed that all the above risk factors were significantly associated with acute myocardial infarction except for alcohol consumption, which showed a weaker association. Smoking and abnormal apolipoprotein ratio showed the strongest association with acute myocardial infarction. The increased risk associated with diabetes and hypertension were found to be higher in women, and the protective effect of exercise and alcohol was also found to be higher in women. [5]

Other risk factors include a moderately high level of plasma homocysteine, which is an independent risk factor of MI. Elevated plasma homocysteine is potentially modifiable and can be treated with folic acid, vitamin B6, and vitamin B12. [7]

Some non-modifiable risk factors for myocardial infarction include advanced age, male gender (males tend to have myocardial infarction earlier in life), genetics (there is an increased risk of MI if a first-degree relative has a history of cardiovascular events before the age of 50). [6] [8]  The role of genetic loci that increase the risk for MI is under active investigation. [9] [10]

• Risk Factors

The most common cause of death and disability in the western world and worldwide is coronary artery disease. [11]  Based on 2015 mortality data from the National Health Interview Survey (NHIS-CDC), MI mortality was 114,023, and MI any-mention mortality (i.e., MI is mentioned as a contributing factor in the death certificate) was 151,863.

As per the National Health and Nutrition Examination Survey (NHANES)-CDC data from 2011 to 2014, an estimated 16.5 million Americans older than 20 years of age have coronary artery disease, and the prevalence was higher in males than females for all ages. As per the NHANES 2011 through 2014, the overall prevalence of MI is 3.0% in U.S. adults older than 20 years of age.

Prevalence of MI in the US Sub-Populations

Non-Hispanic Whites

• 4.0% (Male)
• 2.4% (Female)

Non-Hispanic Blacks

• 3.3% (Male)
• 2.2% (Female)
• 2.9% (Male)
• 2.1% (Female)

Non-Hispanic Asians

• 2.6% (Male)
• 0.7% (Female)

Based on the Atherosclerosis Risk in Communities Study (ARIC) performed by National Heart, Lung, and Blood Institute (NHLBI) collected between 2005 and 2014; the estimated annual incidence is 605,000 new MIs and 200,000 recurrent MIs. [12]

The ARIC study also found that the average age at first MI is 65.6 years for males and 72.0 years for females. In the past decades, several studies have shown a declining incidence of MI in the United States. [12]

The imbalance between oxygen supply and the demand leads to myocardial ischemia and can sometimes lead to myocardial infarction. The patient’s history, electrocardiographic findings, and elevated serum biomarkers help identify ischemic symptoms. Myocardial ischemia can present as chest pain, upper extremity pain, mandibular, or epigastric discomfort that occurs during exertion or at rest. Myocardial ischemia can also present as dyspnea or fatigue, which are known to be ischemic equivalents. [13]  The chest pain is usually retrosternal and is sometimes described as the sensation of pressure or heaviness. The pain often radiates to the left shoulder, neck, or arms with no obvious precipitating factors, and it may be intermittent or persistent. The pain usually lasts for more than 20 minutes. [14]  It is usually not affected by positional changes or active movement of the region. Additional symptoms, such as sweating, nausea, abdominal pain, dyspnea, and syncope, may also be present. [13] [15] [16]  The MI can also present atypically with subtle findings such as palpitations, or more dramatic manifestations, such as cardiac arrest. MI can sometimes occur with no symptoms. [17]

The three components in the evaluation of the MI are clinical features, ECG findings, and cardiac biomarkers.

The resting 12 lead ECG is the first-line diagnostic tool for the diagnosis of acute coronary syndrome (ACS). It should be obtained within 10 minutes of the patient’s arrival in the emergency department. [16]  Acute MI is often associated with dynamic changes in the ECG waveform. Serial ECG monitoring can provide important clues to the diagnosis if the initial EKG is non-diagnostic at initial presentation. [13]  Serial or continuous ECG recordings may help determine reperfusion or re-occlusion status. A large and prompt reduction in ST-segment elevation is usually seen in reperfusion. [13]

ECG findings suggestive of ongoing coronary artery occlusion (in the absence of left ventricular hypertrophy and bundle branch block): [18]

ST-segment elevation in two contiguous lead (measured at J-point) of

• Greater than 5 mm in men younger than 40 years, greater than 2 mm in men older than 40 years, or greater than 1.5 mm in women in leads V2-V3 and/or
• Greater than 1 mm in all other leads

ST-segment depression and T-wave changes

• New horizontal or down-sloping ST-segment depression greater than 5 mm in 2 contiguous leads and/or T inversion greater than 1 mm in two contiguous leads with prominent R waves or R/S ratio of greater than 1

The hyperacute T-wave amplitude, with prominent symmetrical T waves in two contiguous leads, may be an early sign of acute MI that may precede the ST-segment elevation. Other ECG findings associated with myocardial ischemia include cardiac arrhythmias, intraventricular blocks, atrioventricular conduction delays, and loss of precordial R-wave amplitude (less specific finding). [13]

ECG findings alone are not sufficient to diagnose acute myocardial ischemia or acute MI as other conditions such as acute pericarditis, left ventricular hypertrophy (LVH), left bundle branch block (LBBB), Brugada syndrome, Takatsubo syndrome (TTS), and early repolarization patterns also present with ST deviation.

ECG changes associated with prior MI (in the absence of left ventricular hypertrophy and left bundle branch block):

• Any Q wave in lead V2-V3 greater than 0.02 s or QS complex in leads V2-V3
• Q wave > 03 s and greater than 1 mm deep or QS complex in leads I, II, aVL, aVF or V4-V6 in any two leads of contiguous lead grouping (I, aVL; V1-V6; II, III, aVF)
• R wave > 0.04 s in V1-V2 and R/S greater than 1 with a concordant positive T wave in the absence of conduction defect

Biomarker Detection of MI

Cardiac troponins (I and T) are components of the contractile apparatus of myocardial cells and expressed almost exclusively in the heart. Elevated serum levels of cardiac troponin are not specific to the underlying mode of injury (ischemic vs. tension) [13]   [19] . The rising and/or falling pattern of cardiac troponins (cTn) values with at least one value above the 99 percentile of upper reference limit (URL) associated with symptoms of myocardial ischemia would indicate an acute MI. Serial testing of cTn values at 0 hours, 3 hours, and 6 hours would give a better perspective on the severity and time course of the myocardial injury. Depending on the baseline cTn value, the rising/falling pattern is interpreted. If the cTn baseline value is markedly elevated, a minimum change of greater than 20% in follow up testing is significant for myocardial ischemia. Creatine kinase MB isoform can also be used in the diagnosis of MI, but it is less sensitive and specific than cTn level. [4] [20]

Different imaging techniques are used to assess myocardial perfusion, myocardial viability, myocardial thickness, thickening and motion, and the effect of myocyte loss on the kinetics of para-magnetic or radio-opaque contrast agents indicating myocardial fibrosis or scars. [13]  Some imaging modalities that can be used are echocardiography, radionuclide imaging, and cardiac magnetic resonance imaging (cardiac MRI). Regional wall motion abnormalities induced by ischemia can be detected by echocardiography almost immediately after the onset of ischemia when greater than 20% transmural myocardial thickness is affected. Cardiac MRI provides an accurate assessment of myocardial structure and function. [13]

• Medical Management

Acute Management

Reperfusion therapy is indicated in all patients with symptoms of ischemia of less than 12-hour duration and persistent ST-segment elevation. Primary percutaneous coronary intervention (PCI) is preferred to fibrinolysis if the procedure can be performed <120 minutes of ECG diagnosis. If there is no immediate option of PCI (>120 minutes), fibrinolysis should be started within 10 minutes of STEMI after ruling out contraindications. If transfer to a PCI center is possible in 60 to 90 minutes after a bolus of the fibrinolytic agent and patient meets reperfusion criteria, a routine PCI can be done, or a rescue PCI can be planned. [18] [16]  If fibrinolysis is planned, it should be carried out with fibrin-specific agents such as tenecteplase, alteplase, or reteplase (class I). [18]

Relief of pain, breathlessness, and anxiety: The chest pain due to myocardial infarction is associated with sympathetic arousal, which causes vasoconstriction and increased workload for the ischemic heart. Intravenous opioids (e.g., morphine) are the analgesics most commonly used for pain relief (Class IIa). [18]  The results from CRUSADE quality improvement initiative have shown that the use of morphine may be associated with a higher risk of death and adverse clinical outcomes. [21]  The study was done from the CIRCUS (Does Cyclosporine Improve outcome in STEMI patients) database, which showed no significant adverse events associated with morphine use in a case of anterior ST-segment elevation MI. [22] A mild anxiolytic (usually a benzodiazepine) may be considered in very anxious patients (class IIa). Supplemental oxygen is indicated in patients with hypoxemia (SaO2 < 90% or PaO2 < 60mm Hg) (Class I). [18]

Nitrates: Intravenous nitrates are more effective than sublingual nitrates with regard to symptom relief and regression of ST depression (NSTEMI). The dose is titrated upward until symptoms are relieved, blood pressure is normalized in hypertensive patients, or side effects such as a headache and hypotension are noted. [16]

Beta-blockers: This group of drugs reduces myocardial oxygen consumption by lowering heart rate, blood pressure, and myocardial contractility. They block beta receptors in the body, including the heart, and reduce the effects of circulating catecholamines. Beta-blockers should not be used in suspected coronary vasospasm or cocaine use.

Platelet inhibition: Aspirin is recommended in both STEMI and NSTEMI in an oral loading dose of 150 to 300 mg (non-enteric coated formulation) and a maintenance dose of 75 to 100 mg per day long-term regardless of treatment strategy (class I). [16] Aspirin inhibits thromboxane A2 production throughout the lifespan of the platelet. [23]

Most P2Y12 inhibitors are inactive prodrugs (except for ticagrelor, which is an orally active drug that does not require activation) that require oxidation by hepatic cytochrome P450 system to generate an active metabolite which selectively inhibits P2Y12 receptors irreversibly. Inhibition of P2Y12 receptors leads to inhibition of ATP induced platelet aggregation. The commonly used P2Y12 inhibitors are clopidogrel, prasugrel, and ticagrelor.

The loading dose for clopidogrel is 300 to 600 mg loading dose followed by 75 mg per day.

Prasugrel, 60 mg loading dose, and 10 mg per day of a maintenance dose have a faster onset when compared to clopidogrel. [18]

Patients undergoing PCI should be treated with dual antiplatelet therapy (DAPT) with aspirin + P2Y12 inhibitor and a parenteral anticoagulant. In PCI, the use of prasugrel or ticagrelor is found to be superior to clopidogrel. Aspirin and clopidogrel are also found to decrease the number of ischemic events in NSTEMI and UA. [16]

The anticoagulants used during PCI are unfractionated heparin, enoxaparin, and bivalirudin. The bivalirudin is recommended during primary PCI if the patient has heparin-induced thrombocytopenia. [18]

Long-Term Management

Lipid-lowering treatment: It is recommended to start high-intensity statins that reduce low-density lipoproteins (LDLs) and stabilize atherosclerotic plaques. High-density lipoproteins are found to be protective. [18]

Anti-thrombotic therapy: Aspirin is recommended lifelong, and the addition of another agent depends on the therapeutic procedure done, such as PCI with stent placement.

ACE inhibitors are recommended in patients with systolic left ventricular dysfunction, or heart failure, hypertension, or diabetes.

Beta-blockers are recommended in patients with LVEF less than 40% if no other contraindications are present.

Anti-hypertensive therapy can maintain a blood pressure goal of less than 140/90 mm Hg.

Mineralocorticoid receptor antagonist therapy is recommended in a patient with left ventricular dysfunction (LVEF less than 40%).

Glucose lowering therapy in people with diabetes to achieve current blood sugar goals.  [18]

Lifestyle Modifications

Smoking cessation is the most cost-effective secondary measure to prevent MI. Smoking has a pro-thrombotic effect, which has a strong association with atherosclerosis and myocardial infarction. [6]

Diet, alcohol, and weight control: A diet low in saturated fat with a focus on whole grain products, vegetables, fruits, and the fish is considered cardioprotective. The target level for bodyweight is body mass index of 20 to 25 kg/m2  and waist circumference of <94 cm for the men and <80 cm for the female. [24]

• Nursing Management
• Monitor vital signs
• Administer nitroglycerin as ordered
• Check labs for levels of troponin
• Check chest x-ray report as congestive heart failure is not uncommon
• Listen to the lungs for rales and crackles
• Check for edema
• Comfort patient
• Provide a quiet room
• Provide oxygen is saturations are less than 94%
• Have two large-bore IVs
• Quantify type, characteristic and intensity of pain
• Administer beta-blockers, aspirin, morphine as prescribed
• Weigh the patient to ensure they are not fluid overloaded
• Provide adequate bed rest
• When To Seek Help
• Loss of consciousness
• Altered mental status
• New onset loud murmur (Think MR or septal rupture)
• No urine output
• Lable blood pressure
• Outcome Identification
• Normal vitals
• No chest pain
• Warm moist skin
• Coordination of Care

The key to the management of MI is time until treatment. Thus, healthcare professionals, including nurses who work in the emergency department, must be familiar with the symptoms of MI and the importance of rapid triage. A cardiology consult should be made immediately to ensure that the patient gets treated within the time frame recommendations. Because MI can be associated with several serious complications, these patients are best managed in an ICU setting.

• Health Teaching and Health Promotion

The diagnosis and management of patients with ischemic heart disease are best done with an interprofessional team. In fact, in most hospitals, there are cardiology teams that are dedicated to the management of these patients.

For patients who present with chest pain, the key to the management of MI is time to treatment. Thus, healthcare professionals, including nurses who work in the emergency department, must be familiar with the symptoms of MI and the importance of rapid triage. A cardiology consult should be made immediately to ensure that the patient gets treated within the time frame recommendations. Because MI can be associated with several serious complications, these patients are best managed in an ICU setting.

There is no cure for ischemic heart disease, and all treatments are symptom-oriented. The key to improving outcomes is to prevent coronary artery disease. The primary care provider and nurse practitioner should educate the patient on the benefits of a healthy diet, the importance of controlling blood pressure and diabetes, exercising regularly, discontinuing smoking, maintaining healthy body weight, and remaining compliant with medications. The pharmacist should educate the patient on types of medication used to treat ischemic heart disease, their benefits, and potential adverse effects.

Only through such a team approach can the morbidity and mortality of myocardial infarction be lowered.

• Review Questions
• Access free multiple choice questions on this topic.
• Comment on this article.

Myocardial Infarction (Heart Attack) Warning Signs in Women. U.S. Department of Health and Human Services Office on Women's Health

ECG With Pardee Waves Indicating AMI. Pardee waves indicate acute myocardial infarction in the inferior leads II, III, and aVF with reciprocal changes in the anterolateral leads. Wikimedia Commons, Glenlarson

Transesophageal echocardiography, Thrombo embolism, Pulmonary artery, Pulmonary Embolism, Thromboembolic , Right Pulmonary artery, TE, RPA, Acute ECG segment elevation mimicking myocardial infarction in a patient with pulmonary embolism Contribute by (more...)

Ischemic ventricular tachycardia in a patient with an old inferior myocardial infarction Contributed by Alina Negru, MD

Disclosure: Niranjan Ojha declares no relevant financial relationships with ineligible companies.

Disclosure: Amit Dhamoon declares no relevant financial relationships with ineligible companies.

Disclosure: Rojeena Chapagain declares no relevant financial relationships with ineligible companies.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

• Cite this Page Ojha N, Dhamoon AS, Chapagain R. Myocardial Infarction (Nursing) [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

In this Page

Bulk download.

• Bulk download StatPearls data from FTP

Related information

• PMC PubMed Central citations
• PubMed Links to PubMed

Similar articles in PubMed

• Myocardial Infarction. [StatPearls. 2024] Myocardial Infarction. Ojha N, Dhamoon AS. StatPearls. 2024 Jan
• Review Context-independent identification of myocardial ischemia in the prehospital ECG of chest pain patients. [J Electrocardiol. 2024] Review Context-independent identification of myocardial ischemia in the prehospital ECG of chest pain patients. Swenne CA, Ter Haar CC. J Electrocardiol. 2024 Jan-Feb; 82:34-41. Epub 2023 Nov 7.
• Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. [Ont Health Technol Assess Ser....] Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser. 2006; 6(5):1-70. Epub 2006 Mar 1.
• Association of Silent Myocardial Infarction and Sudden Cardiac Death. [JAMA Cardiol. 2019] Association of Silent Myocardial Infarction and Sudden Cardiac Death. Vähätalo JH, Huikuri HV, Holmström LTA, Kenttä TV, Haukilahti MAE, Pakanen L, Kaikkonen KS, Tikkanen J, Perkiömäki JS, Myerburg RJ, et al. JAMA Cardiol. 2019 Aug 1; 4(8):796-802.
• Review Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease? [Am J Ther. 2004] Review Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease? Bacaner M, Brietenbucher J, LaBree J. Am J Ther. 2004 Sep-Oct; 11(5):366-411.

Recent Activity

• Myocardial Infarction (Nursing) - StatPearls Myocardial Infarction (Nursing) - StatPearls

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Connect with NLM

National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894

Web Policies FOIA HHS Vulnerability Disclosure

Help Accessibility Careers